• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胃肠道癌症中的激肽释放酶相关肽酶:对其作用和临床意义的深入了解

Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.

作者信息

Linardoutsos Dimitrios, Gazouli Maria, Machairas Anastasios, Bramis Ioannis, Zografos Georgios C

机构信息

1st Department of Propaedeutic Surgery, Hippocration General Hospital, School of Medicine, University of Athens, Athens, Greece.

出版信息

J BUON. 2014 Jan-Mar;19(1):53-9.

PMID:24659643
Abstract

Human tissue kallikrein (KLK1) and is related peptidases (KLK2-KLK15) are a family of 15 homologous serine proteases, participating in numerous processes of normal physiology. Considering the irreversible impact of proteases on substrates, the tissue-dependent regulation of KLKs activity becomes crucial for their beneficial role in normal homeostasis. Moreover, KLKs expression is strongly regulated at the transcriptional and post-transcriptional level by steroid hormones and miRNAs, respectively. Deregulation of KLKs expression, secretion and/or activation has been observed in most human malignancies and there is a trend to identify their role in the multi-complex process of cancer development. The identification of extracellular matrix (ECM) proteins, cell-surface receptors, cell-surface adhesion molecules and growth factors among substrates, clearly support the driving role of KLK abnormal expression and function during tumorigenesis and cancer progression. KLKs have also clinical utility in cancer diagnosis and monitoring like KLK 3 (PSA) in prostate cancer. In this review, we tried to summarize the existing literature about the role of KLKs in gastrointestinal cancers as well as to emphasize their clinical significance for patients' prognosis.

摘要

人组织激肽释放酶(KLK1)及其相关肽酶(KLK2 - KLK15)是一个由15种同源丝氨酸蛋白酶组成的家族,参与众多正常生理过程。鉴于蛋白酶对底物具有不可逆的影响,KLKs活性的组织依赖性调节对于其在正常体内平衡中的有益作用至关重要。此外,KLKs的表达分别在转录水平和转录后水平受到类固醇激素和微小RNA的强烈调控。在大多数人类恶性肿瘤中均观察到KLKs表达、分泌和/或激活失调,并且存在一种趋势,即确定它们在癌症发展的多复杂过程中的作用。在底物中鉴定出细胞外基质(ECM)蛋白、细胞表面受体、细胞表面黏附分子和生长因子,这明确支持了KLK异常表达和功能在肿瘤发生和癌症进展过程中的驱动作用。KLKs在癌症诊断和监测方面也具有临床应用价值,如前列腺癌中的KLK 3(PSA)。在本综述中,我们试图总结关于KLKs在胃肠道癌症中作用的现有文献,并强调它们对患者预后的临床意义。

相似文献

1
Kallikrein-related peptidases in cancers of gastrointestinal tract: an inside view of their role and clinical significance.胃肠道癌症中的激肽释放酶相关肽酶:对其作用和临床意义的深入了解
J BUON. 2014 Jan-Mar;19(1):53-9.
2
Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance.激肽释放酶相关肽酶在前列腺癌、乳腺癌和卵巢癌中的作用:从病理生物学到临床相关性。
Biol Chem. 2012 Apr;393(5):301-17. doi: 10.1515/hsz-2011-0260.
3
Predictions for the future of kallikrein-related peptidases in molecular diagnostics.预测激肽释放酶相关肽酶在分子诊断学中的未来。
Expert Rev Mol Diagn. 2014 Jul;14(6):713-22. doi: 10.1586/14737159.2014.928207. Epub 2014 Jun 13.
4
Kallikrein-related peptidases (KLKs) in gastrointestinal cancer: mechanistic and clinical aspects.激肽释放酶相关肽酶(KLKs)在胃肠癌中的作用机制和临床方面。
Thromb Haemost. 2013 Sep;110(3):450-7. doi: 10.1160/TH12-11-0791. Epub 2013 Feb 28.
5
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies.激肽释放酶相关肽酶基因作为人类恶性肿瘤预后和监测的有希望的生物标志物。
Biol Chem. 2010 May;391(5):505-11. doi: 10.1515/BC.2010.056.
6
Clinical utility of kallikrein-related peptidases (KLK) in urogenital malignancies.激肽释放酶相关肽酶(KLK)在泌尿生殖系统恶性肿瘤中的临床应用。
Thromb Haemost. 2013 Sep;110(3):408-22. doi: 10.1160/TH13-03-0206. Epub 2013 Jun 13.
7
Epigenetic regulation of kallikrein-related peptidases: there is a whole new world out there.激肽释放酶相关肽酶的表观遗传调控:全新的世界。
Biol Chem. 2012 Apr;393(5):319-30. doi: 10.1515/hsz-2011-0273.
8
The kallikrein-related peptidase family: Dysregulation and functions during cancer progression.激肽释放酶相关肽酶家族:癌症进展过程中的失调与功能
Biochimie. 2016 Mar;122:283-99. doi: 10.1016/j.biochi.2015.09.002. Epub 2015 Sep 4.
9
Kallikrein-related peptidases (KLKs) as emerging therapeutic targets: focus on prostate cancer and skin pathologies.激肽释放酶相关肽酶(KLKs)作为新兴治疗靶点:聚焦于前列腺癌和皮肤疾病
Expert Opin Ther Targets. 2016 Jul;20(7):801-18. doi: 10.1517/14728222.2016.1147560. Epub 2016 Mar 4.
10
Interdependence of kallikrein-related peptidases in proteolytic networks.激肽释放酶相关肽酶在蛋白水解网络中的相互依存关系。
Biol Chem. 2010 May;391(5):581-7. doi: 10.1515/BC.2010.055.

引用本文的文献

1
Kallikrein-related peptidase 7 is a potential target for the treatment of pancreatic cancer.激肽释放酶相关肽酶7是胰腺癌治疗的一个潜在靶点。
Oncotarget. 2018 Jan 10;9(16):12894-12906. doi: 10.18632/oncotarget.24132. eCollection 2018 Feb 27.
2
Global analysis of gene expression profiles in the submandibular salivary gland of klotho knockout mice.klotho 基因敲除小鼠下颌下腺基因表达谱的全球分析。
J Cell Physiol. 2018 Apr;233(4):3282-3294. doi: 10.1002/jcp.26172. Epub 2017 Sep 28.
3
Serum human kallikrein 7 represents a new marker for cervical cancer.
血清人激肽释放酶7是宫颈癌的一种新标志物。
Med Oncol. 2014 Oct;31(10):208. doi: 10.1007/s12032-014-0208-0. Epub 2014 Sep 3.